Literature DB >> 15170888

Surgery of cavoatrial tumor thrombus in nephroblastoma: a report of the SIOP/GPOH study.

Philipp Szavay1, Tobias Luithle, Oliver Semler, Norbert Graf, Joerg Fuchs.   

Abstract

BACKGROUND: Resection of a Wilms tumor extending through the inferior vena cava into the right atrium represents a challenge to the pediatric surgeon. Exact preoperative diagnosis is essential to identify the tumor and its intravascular extension. To achieve a complete excision of the tumor cardiopulmonary bypass and hypothermia may be required. The feasibility of a complete resection is important as it guides subsequent therapy such as chemotherapy and radiation. PROCEDURE: In order to define these issues, we reviewed the records of 33 of 1,151. Patients enrolled in the SIOP 93-01/GPOH Study and the SIOP 2001/GPOH Study who had a tumor thrombus into the inferior vena cava and into the right atrium.
RESULTS: The median age at diagnosis was 3.73 years. Twenty-four patients had a tumor thrombus into the inferior vena cava, in nine patients the thrombus reached into the right atrium. All patients were operated on; cardiopulmonary bypass was used in nine patients. There were no deaths intraoperatively. Twenty-nine children are still alive; four patients died, one patient due to aspiration and failed resuscitation, two patients died from a recurrent tumor, and one child due to an unresectable primary tumor.
CONCLUSION: Our report suggests that Wilms tumor extending to the inferior vena cava and the right atrium is technical challenging, but with adequate preoperative diagnosis and a multidisciplinary surgical approach including cardiopulmonary bypass and hypothermia, the prognosis is favorable. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15170888     DOI: 10.1002/pbc.20056

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  15 in total

1.  Inferior vena cava involvement in children with Wilms tumor.

Authors:  Abeer Al Diab; Nader Hirmas; Abdellatif Almousa; Ramiz Abu-Hijlih; Fatinah Aljlouni; Iyad Sultan; Khalil Ghandour
Journal:  Pediatr Surg Int       Date:  2017-01-09       Impact factor: 1.827

2.  Nonresponsiveness to chemotherapy: a formidable surgical challenge in wilms' tumor with intracardiac extension.

Authors:  Sandesh V Parelkar; Dinesh Mundada; Sanjay N Oak; Beejal V Sanghvi; Prashant B Joshi; Satish P Kapadnis; D K Kulkarni
Journal:  Indian J Surg Oncol       Date:  2013-07-11

Review 3.  Wilms tumor.

Authors:  Andrew M Davidoff
Journal:  Adv Pediatr       Date:  2012

4.  The management of nephroblastoma with cavo-atrial disease at presentation: experience from a developing country.

Authors:  G P Hadley; M H Sheik-Gafoor; N J Buckels
Journal:  Pediatr Surg Int       Date:  2010-08-10       Impact factor: 1.827

5.  A surgical approach to Wilms' tumour with retrohepatic vena caval extension.

Authors:  Mohammad I Bader; Khaled Abdelaal; Timothy Rogers; Suren G Arul
Journal:  Pediatr Surg Int       Date:  2013-01-24       Impact factor: 1.827

Review 6.  [Surgical concepts in the treatment of Wilms tumor: An update].

Authors:  J Fuchs
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

Review 7.  Wilms' tumor.

Authors:  Andrew M Davidoff
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

8.  Surgical management and outcomes of 12 cases of Wilms tumour with intracardiac extension from a single centre.

Authors:  Sharon G Cox; A Davidson; J Thomas; A Brooks; J Hewitson; A Numanoglu; A J W Millar
Journal:  Pediatr Surg Int       Date:  2017-10-11       Impact factor: 1.827

9.  Wilms tumor with intravascular tumor thrombus.

Authors:  Suna Emir
Journal:  Transl Pediatr       Date:  2014-01

10.  Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis.

Authors:  T D Boam; M Gabriel; R Shukla; P D Losty
Journal:  BJS Open       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.